Results 181 to 190 of about 7,727 (212)

Organ‐Specific Human Microbiomes and Dysbiosis: Mechanistic Links to Disease and Emerging Therapeutic Strategies

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Schematic overview of the human microbiome and major microbiota‐derived metabolites across body sites, highlighting the gut–brain, gut–heart, and gut–kidney axes in host physiology and disease. ABSTRACT Background The human microbiome is a dynamic and diverse community of microorganisms that affects susceptibility to illness and promotes wellness ...
Awadh Alanazi
wiley   +1 more source

Safety evaluation of an extension of use of the food enzyme endo-1,4-β-xylanase from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-FX. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +14 more
europepmc   +1 more source

Gingival inflammation and plaque accumulation affect therapeutic outcomes in patients with acne vulgaris

open access: yesJournal of Periodontology, EarlyView.
Abstract Background We hypothesized that acne vulgaris (AV) and gingivitis were associated through systemic inflammatory mechanisms, sharing common etiological factors. This study aimed to identify the association between AV and gingivitis and to assess changes in acne severity in relation to changes in the plaque index (PI).
Ömer Faruk Okumuş   +2 more
wiley   +1 more source

Looking at Soil as It Is: Evolution of Microscopic Soil Characterization From Kubiëna to Artificial Intelligence

open access: yesJournal of Plant Nutrition and Soil Science, EarlyView.
We provide a historic overview of microscopic soil structure characterization from its founding father, Walter Kubiëna, to several technical revolutions like automation, digitalization, and artificial intelligence. In addition to technical advancements, we explore how concepts and research questions have evolved in time.
Steffen Schlüter   +3 more
wiley   +1 more source

Update of the list of QPS-recommended biological agents intentionally added to food or feeds as notified to EFSA. [PDF]

open access: yesEFSA J
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
europepmc   +1 more source

Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single‐centre Australian experience

open access: yesJPGN Reports, EarlyView.
Abstract Objectives To evaluate the durability and predictors of loss of response of infliximab (IFX) over 2 years in paediatric Crohn's disease (CD) utilizing a proactive therapeutic drug monitoring (TDM) strategy. Methods A retrospective, single‐centre cohort study was conducted at The Children's Hospital at Westmead (CHW), Australia, from January ...
Cher Wei Chuah   +9 more
wiley   +1 more source

Safety evaluation of a food enzyme containing leucyl aminopeptidase, oryzin and aspergillopepsin I from the non-genetically modified <i>Aspergillus</i> sp. strain AE-PR. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +17 more
europepmc   +1 more source

Literature horizon scan for new scientific data on plants, microorganisms and animals, and their products obtained by new genomic techniques (October 2025). [PDF]

open access: yesEFSA J
European Food Safety Authority (EFSA)   +12 more
europepmc   +1 more source

Safety and efficacy of a feed additive consisting of l-valine produced with <i>Corynebacterium glutamicum</i>CCTCC M 20232578 for all animal species (Kempex Holland B.V.). [PDF]

open access: yesEFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy